Financial comparisons Bright Minds Biosciences Inc.

Stocks

Market Closed - Canadian Securities Exchange Other stock markets 19:09:58 16/06/2026 BST			5-day change	1st Jan Change
83.40 ^CAD	-1.27%		-6.86%	-24.48%

05-19	Bright Minds Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
04-08	Certain RSUs of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (N-1)	Net Margin (N-1)	EBIT Margin (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
LONZA GROUP AG	8.24B	14.53%	21.7%	10.28%	4.9%	1.58x
IQVIA HOLDINGS INC.	16.31B	8.34%	13.38%	32.9%	4.79%	3.63x
BEONE MEDICINES AG	5.34B	5.37%	8.37%	29.84%	16.27%	-5.99x
CELLTRION, INC.	2.88B	24.74%	28.07%	5.94%	4.75%	1.77x
ASCENDIS PHARMA A/S	846M	-31.67%	-18.92%	-	-	1.57x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
EUROFINS SCIENTIFIC SE	8.57B	6.51%	14.79%	9.61%	4.34%	2.22x
IONIS PHARMACEUTICALS, INC.	944M	-40.36%	-40.47%	-70.72%	-11.67%	4.51x
ICON PUBLIC LIMITED COMPANY	8.25B	2.78%	16.66%	10.62%	6.02%	1.8x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.02B	-3.59%	19.77%	15.46%	6.99%	1.98x
TEMPUS AI, INC.	1.27B	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
BIO-TECHNE CORPORATION	1.22B	6.02%	31.45%	15.37%	11.65%	0.43x
ABIVAX	5.4M	-7,306.52%	-5,350%	-135.58%	-	2.1x
QIAGEN N.V.	2.09B	20.33%	29.46%	17.5%	10.73%	0.74x
ALKERMES PLC	1.48B	16.37%	17.21%	14.72%	10.64%	-2.06x
KYMERA THERAPEUTICS, INC.	39.21M	-794.04%	-891.07%	-25.78%	-22.89%	4.75x
Average	4B	-504.54%	-380.15%	-2.55%	4.43%	-2.97x
Weighted average by Cap.	5.71B	-248.07%	-181.97%	7.18%	5.89%	-1.59x